This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Stocks in play: Spectral Medical Inc

Baystreet.ca - Baystreet - Thu Feb 26, 2:33PM CST

Today provided an update on the timing of its Premarket Approval submission to the U.S. Food and Drug Administration for its hemoadsorption device to treat endotoxic septic shock. Spectral Medical Inc shares T.EDT are trading down $0.03 at $1.36.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).